Pharmacokinetic evaluations of low- and high-dose zidovudine plus high-dose acyclovir in patients with symptomatic human immunodeficiency virus infection.

The pharmacokinetics of zidovudine were evaluated in 41 patients with Centers for Disease Control HIV class IVA infection. The patients were assigned escalating doses of zidovudine (300, 600, or 1,500 mg daily) and were randomized to receive either zidovudine alone or zidovudine with a high dose of...

Ausführliche Beschreibung

Bibliografische Detailangaben

Veröffentlicht in:	Antimicrob Agents Chemother
Hauptverfasser:	Tartaglione, T A, Collier, A C, Opheim, K, Gianola, F G, Benedetti, J, Corey, L
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	American Society for Microbiology (ASM) 1991
Schlagworte:	Research Article
Online-Zugang:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC245364/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/1803995/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.35.11.2225
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!